Sean E. Browne
Net Worth
Last updated:
What is Sean E. Browne net worth?
The estimated net worth of Mr. Sean E. Browne is at least $4,635,115 as of 19 Oct 2022. He owns shares worth $979,280 as insider, has earned $85,835 from insider trading and has received compensation worth at least $3,570,000 in Xtant Medical Holdings, Inc..
What is the salary of Sean E. Browne?
Mr. Sean E. Browne salary is $1,190,000 per year as Pres, Chief Executive Officer & Director in Xtant Medical Holdings, Inc..
How old is Sean E. Browne?
Mr. Sean E. Browne is 59 years old, born in 1966.
What stocks does Sean E. Browne currently own?
As insider, Mr. Sean E. Browne owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | Pres, Chief Executive Officer & Director | 1,506,584 | $0.65 | $979,280 |
What does Xtant Medical Holdings, Inc. do?
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor, which contains various proteins and peptides that support bone formation and remodeling; OsteoWrap; and OsteoVive Plus, a growth factor enriched cellular bone matrix. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, Xpress minimally invasive pedicle screw, and Fortex Pedicle screw systems. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
Sean E. Browne insider trading
Xtant Medical Holdings, Inc.
Mr. Sean E. Browne has made 2 insider trades in 2022, according to the Form 4 filled with the SEC. Most recently he sold 51,100 units of XTNT stock worth $31,835 on 19 Oct 2022.
The largest trade he's ever made was exercising 80,000 units of XTNT stock on 18 Oct 2022. As of 19 Oct 2022 he still owns at least 1,506,584 units of XTNT stock.
Xtant Medical Holdings key executives
Xtant Medical Holdings, Inc. executives and other stock owners filed with the SEC:
- Mr. Kevin D. Brandt (59) Senior Vice President & Chief Commercial Officer
- Mr. Sean E. Browne (59) Pres, Chief Executive Officer & Director